Nigel Graham Cooke,Paulo Antonio Fernandes Gomes Dos Santos,Pascal Furet,Christina Hebach,Klemens Hoegenauer,Gregory Hollingworth,Christoph Kalis,Ian Lewis,Alexander Baxter Smith,Nicolas Soldermann,Fr
申请号：
US14365512
公开号：
US09949979B2
申请日:
2012.12.14
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The invention relates to new uses of PI3K inhibitors, wherein said inhibitors have an inhibitory action on the PI3K isoform delta for the treatment of immunopathology in a subject suffering from a disease or disorder selected from malaria, leishmaniasis, trypanosomiasis, toxoplasmosis and/or neurocysticercosis, via functional inhibition of TLR9 of the infected subject.
